Susanta Samajdar

9 Patents

• US125706502026

  6-substituted Pyridazine Compounds as SMARCA2 And/or SMARCA4 Degraders

  Aurigene Oncology Limited

  0 cites
• US124283792025

  Acylsulfonamide KAT6A Inhibitors

  Aurigene Oncology Limited

  0 cites
• US124101932025

  Bicyclic Heterocyclyl Derivatives as IRAK4 Inhibitors

  Aurigene Oncology Limited

  0 cites
• US123714262025

  Pyridazine Derivatives as SMARCA2/4 Degraders

  0 cites
• US123310232025

  Substituted Heterocyclyl Derivatives as CDK Inhibitors

  Aurigene Oncology Limited

  0 cites
• US119816852024

  Bicyclic Heterocyclyl Derivatives as IRAK4 Inhibitors

  Aurigene Oncology Limited

  0 cites
• US118651142024

  Method for Treating Diseases Using SMARCA2/4 Degraders

  Aurigene Oncology Limited

  0 cites
• US116919872023

  Bicyclic Heterocyclyl Derivatives as IRAK4 Inhibitors

  Aurigene Discovery Technologies Limited

  0 cites
• US115780522023

  PPAR Agonists, Compounds, Pharmaceutical Compositions, and Methods of Use Thereof

  The Salk Institute For Biological Studies

  0 cites